C

Pfizer Inc. PFE

$28.97 $0.080.26% NYSE
Recommendation
Dividend Power Score
Day's Range
$28.87$29.28
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

PFE Rating

Reward
Risk

PFE Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

PFE Company Overview

Pfizer Inc. is a global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing medicines and vaccines across multiple therapeutic areas. The company operates primarily within the pharmaceutical and biotechnology industries, with products spanning oncology, vaccines, internal medicine, inflammation and immunology, rare disease, and anti-infectives. Pfizer’s major revenue drivers include patented prescription medicines, specialty therapeutics, and vaccines, with significant contributions in recent years from its COVID-19-related products. The company serves hospitals, pharmacies, governments, healthcare providers, and patients globally through both direct commercial operations and distribution partnerships.

Pfizer traces its origins to 1849 when Charles Pfizer and Charles Erhart founded the business in Brooklyn, New York. Over time, the company evolved from a chemicals producer into one of the world’s largest research-based pharmaceutical companies through internal research expansion and major acquisitions. Significant milestones include the acquisitions of Warner-Lambert, Pharmacia, Wyeth, and more recently Seagen. Pfizer has historically positioned itself through large-scale research and development capabilities, broad global commercialization infrastructure, extensive intellectual property portfolios, and strategic partnerships in biotechnology and vaccine development. Information regarding corporate structure and operating strategy is consistently reflected in SEC filings, annual reports, and investor communications.

Data compiled by narrative technology. May contain errors.
Sector

PFE Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

PFE Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

PFE Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

PFE Price History

Loading...
52-Week Range68% of range
Current
$28.97
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

PFE Valuation

Market Cap
Market Cap Rank
#156
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

PFE Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

PFE Corporate Info

Phone Number
212 733 2323
Address
66 Hudson Boulevard East
New York, NY 10001-2192
Country
Year Founded

PFE Filings

Filing Date
Tuesday, November 3, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 22 and 26 (est)

PFE Headlines

11/16/2026 - Pharmaceutical Business Review
11/16/2026 - Simply Wall St
11/14/2026 - Abnormal Returns
11/13/2026 - Zacks Investment Research
11/13/2026 - Zacks Investment Research